Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

  • Read more about Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19)

  • Read more about Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19)

Study on the Antibody Level Against SARS-CoV-2 (COVID-19)in Dazhu County in 2023

  • Read more about Study on the Antibody Level Against SARS-CoV-2 (COVID-19)in Dazhu County in 2023

Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer

  • Read more about Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer

Phase IIB Study of Recombinant Novel Coronavirus Vaccine

  • Read more about Phase IIB Study of Recombinant Novel Coronavirus Vaccine

Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence

  • Read more about Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence

Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients

  • Read more about Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients

A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19

  • Read more about A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19

Variants of SARS-CoV-2 Causing COVID-19 in Africa

  • Read more about Variants of SARS-CoV-2 Causing COVID-19 in Africa

Adaptive Immune Response to COVID-19 Vaccination

  • Read more about Adaptive Immune Response to COVID-19 Vaccination

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • Current page 138
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA